Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-29T11:28:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-22T12:15:43.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-15T12:19:08.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-08T13:55:33.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Added downloadable documents for the study (Statistical Analysis Plan and Study Protocol) along with metadata, and updated record dates and related keywords to reflect current documentation for the trial.
    Difference
    100%
    Check dated 2026-10-01T15:20:11.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message with a simple header and a Home link, and previously available study content and documents are removed; navigation remains possible but the study information is no longer accessible.
    Difference
    18%
    Check dated 2026-09-24T18:35:43.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.